A Case Study - Discover how Catalent used FastChain® Demand-Led Supply to help the sponsor overcome these hurdles and ensure quick delivery and administration of this therapy to patients.

China continues to be a key player in global clinical trials, offering vast opportunities for pharmaceutical innovation.

Learn how to objectively evaluate and ultimately decide whether it is the EU or the UK that best aligns with your clinical supply strategy.

This webinar will discuss various pharmacy solutions available in DTP supply and provide sponsors with key considerations for selecting an appropriate clinical supply provider.

Summary: Learn about Catalent’s global clinical supply network and how trial sponsors can leverage Catalent’s comprehensive capabilities to optimize their clinical supply chains.

Biosimilars can be used in place of a branded drug (if one exists), offering the sponsor a variety of benefits. But what is a biosimilar, exactly? Can a sponsor just replace the branded drug with the biosimilar, or are there certain requirements that need to be met in order to use it in a clinical trial?

Summary: Watch this webinar to learn more about available options within demand-led supply and how they can support clinical trials, especially decentralized studies.

Summary: This executive summary showcases examples of real-life tactical and operational decisions involved in the integrated approach to drug development.

Summary: The growing complexity associated with today’s clinical trials is driving sponsors to deploy non-traditional clinical supply strategies to address their changing needs. This session will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.

Summary: Watch this webinar to learn how to objectively evaluate and decide whether it is the EU or the UK that best aligns with your clinical supply strategy.